Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

The benefits and harms of breast cancer screening: an independent review.

Independent UK Panel on Breast Cancer Screening.

Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30. Review.

PMID:
23117178
2.

Benefits and harms of mammography screening.

Løberg M, Lousdal ML, Bretthauer M, Kalager M.

Breast Cancer Res. 2015 May 1;17:63. doi: 10.1186/s13058-015-0525-z. Review.

3.

Screening for breast cancer with mammography.

Gøtzsche PC, Jørgensen KJ.

Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877. doi: 10.1002/14651858.CD001877.pub5. Review.

4.

Benefits and Harms of Breast Cancer Screening: A Systematic Review.

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD.

JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. Review. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

5.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD001877. doi: 10.1002/14651858.CD001877.pub4. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD001877.

PMID:
21249649
6.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001877. doi: 10.1002/14651858.CD001877.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD001877.

PMID:
19821284
7.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
8.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001877. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD001877.

PMID:
17054145
9.

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.

Jacklyn G, Glasziou P, Macaskill P, Barratt A.

Br J Cancer. 2016 May 24;114(11):1269-76. doi: 10.1038/bjc.2016.90. Epub 2016 Apr 28.

10.

The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.

Broeders M, Paci E.

Womens Health (Lond). 2015 Nov;11(6):883-90. doi: 10.2217/whe.15.34. Epub 2015 Nov 30.

PMID:
26619214
11.

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J.

Breast Cancer Res. 2005;7(6):258-65. Epub 2005 Nov 10.

12.

[Tailored Breast Screening Trial (TBST)].

Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D; TBST Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5):317-27. Italian.

13.

Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.

Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA.

Cancer. 2001 May 1;91(9):1724-31.

PMID:
11335897
14.

Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.

Gunsoy NB, Garcia-Closas M, Moss SM.

Br J Cancer. 2014 May 13;110(10):2412-9. doi: 10.1038/bjc.2014.206. Epub 2014 Apr 24.

15.

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England.

Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA.

J Med Screen. 2010;17(1):25-30. doi: 10.1258/jms.2009.009094. Erratum in: J Med Screen. 2010 Jun;17(2):106.

16.

Benefit-to-harm ratio of the Danish breast cancer screening programme.

Beau AB, Lynge E, Njor SH, Vejborg I, Lophaven SN.

Int J Cancer. 2017 Aug 1;141(3):512-518. doi: 10.1002/ijc.30758. Epub 2017 May 10.

17.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

18.

Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.

[No authors listed]

Prescrire Int. 2015 Jul;24(162):186-9, 191. Review.

PMID:
26240891
19.

Mammography screening. Benefits, harms, and informed choice.

Jørgensen KJ.

Dan Med J. 2013 Apr;60(4):B4614. Review.

PMID:
23651722
20.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

Supplemental Content

Support Center